Five Star Equities Issues New Research Reports on AMZN, FOSL, PCYC and WCG


Follow this company

Companies Mentioned

NASDAQ:AMZN / NASDAQ:FOSL / NASDAQ:PCYC / NYSE:WCG
02/13/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Amazon.com, Inc. (NASDAQ: AMZN) shares declined 3.47 percent to close at $349.25 a share Wednesday. The stock traded between $346.32 and $357.75 on volume 6.59 million shares traded. UBS analyst Eric Sheridan has downgraded the company to “neutral” and has also lowered his price target on the stock to $375.00 from $450.00, as he believes Amazon will have trouble raising the price of its Prime subscription service. Shares of Amazon.com are down approximately 12.0 percent year-to-date.

Get more information on Amazon.com free access to the in-depth equity report at:  
www.FiveStarEquities.com/AMZN

Fossil Group Inc. (NASDAQ: FOSL) shares jumped 3.51 percent to close at $121.06 a share Wednesday. The stock traded between $120.46 and $125.00 on volume of 3.57 million shares traded. The company reported net sales were $1.062 billion for the fourth quarter of 2013, an increase of 12.0 percent when compared to a year ago. Shares of Fossil Group are up approximately 4.0 percent year-to-date.

Get more information on Fossil Group and free access to the in-depth equity report at:  
www.FiveStarEquities.com/FOSL

Pharmacyclics, Inc. (NASDAQ: PCYC) shares spiked 3.12 percent to close at $137.00 a share Wednesday. The stock traded between $130.09 and $142.60 on volume 2.30 million shares traded. The company announced that the FDA has approved IMBRUVICA as a single agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy. Shares of Pharmacyclics are up approximately 30.0 percent year-to-date.

Get more information on Pharmacyclics and free access to the in-depth equity report at:  
www.FiveStarEquities.com/PCYC

WellCare Health Plans, Inc. (NYSE: WCG) shares declined 8.97 percent to close at $56.64 a share Wednesday. The stock traded between $55.16 and $59.26 on volume of 3.01 million shares traded. The company reported a GAAP net income of $42.9 million, or $0.97 per diluted share, for the fourth quarter of 2013, a decrease of 12.0 percent when compared to a year ago. Shares of WellCare Health Plans are down approximately 20.0 percent year-to-date.

Get more information on WellCare Health Plans and free access to the in-depth equity report at:  
www.FiveStarEquities.com/WCG

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:               
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *